Encompass Consortium

Country: Australia

What infection type does your test focus on? Bloodstream Infection, Sepsis

What does your test detect? Pathogen(s), Antibiotic Susceptibility Pattern

About the Team: 

Team: Lab Without Walls Inc., Perth, Western Australia; Cellular Analysis Division, Thermo Fisher Scientific, Eugene, OR, USA; PathWest Laboratory Medicine WA, Western Australia; School of Pathology & Laboratory Medicine, University of Western Australia; Antimicrobial Resistance and Healthcare Associated Infections Reference Unit, Public Health England, Colindale, UK; Norwegian Institute of Public Health, Oslo, Norway; Defence Science and Technology Laboratories, Porton Down, UK; Department of Microbiology, University of Colombo, Sri Lanka.

What we have to offer: We are an inclusive group with a field-led, global health development perspective and a firm grasp on the spread of antimicrobial resistance. We aim to develop PART-ICLE; a small personal antimicrobial resistance test. We will consolidate recently discovered rapid methods for detecting antimicrobial resistance, convert these into a series of standard procedures applicable to a wide range of multi-resistant bacteria, and develop methods that operate on simple, hand-held devices suitable for a range of field applications including point-of-care use. Noting the Millennium Development Goals, the Encompass group recognises the value of combined north-south and south-south cooperation in global health technology development and has mapped out a technology transfer pipeline that spans applied systems biology, an international network of research, public health and clinical microbiology labs and global antimicrobial resistance hotspots.

An accurate, ultrafast MIC method based on bacterial analysis by flow cytometer is under development.